Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Sarcoma 1Myeloid 1

Conditions

Neuroblastoma 7Lymphoma, B-Cell 5Lymphoma 5Rhabdoid Tumor 3Neoplasms 3Medulloblastoma 3Leukemia, Myeloid, Acute 3Leukemia 3Sarcoma, Ewing 2Rhabdomyosarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pinealoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms, Germ Cell and Embryonal 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Immunoblastic Lymphadenopathy 2Hodgkin Disease 2Ganglioneuroblastoma 2Ependymoma 2Enteropathy-Associated T-Cell Lymphoma 2Brain Neoplasms 2Solid Tumor 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrence 1Pyloric Stenosis, Hypertrophic 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1

Interventions

Cyclophosphamide 14Temozolomide 11Vincristine 9Magnetic Resonance Spectroscopy 9Cisplatin 9Etoposide 8Specimen Handling 7Radiotherapy 7X-Rays 6Phantoms, Imaging 6Nuclear Medicine Department, Hospital 5Lomustine 5Carboplatin 5Methotrexate 4Irinotecan 4Biopsy 4etoposide phosphate 3Thiotepa 3Radiation 3Platinum 3Nivolumab 3Filgrastim 3Celecoxib 3Bevacizumab 3Automobiles 31,2-diaminocyclohexaneplatinum II citrate 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Medulloblastoma × etoposide phosphate × 1 year × Clear all
NCT02574728 2026-03-02

AflacST1502

Emory University

Phase 2 Active not recruiting
46 enrolled
CNSMyeloidSarcoma

Brain Neoplasms, Carcinoma, Ependymoma, Histiocytosis, Langerhans-Cell, Medulloblastoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Neuroblastoma, Pinealoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Rhabdoid Tumor

NCT06942039 2026-02-27

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

C17 Council

Phase EARLY_PHASE1 Recruiting
15 enrolled
CNS

Medulloblastoma, Neuroblastoma, Pinealoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor, Pyloric Stenosis, Hypertrophic

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting
232 enrolled
CNS

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡